IMMUNOTHERAPY OF SEPSIS

[1] BAUMGARTNER JD, 1987, REV INFECT DIS, V9, P194

[2] ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTI-LIPOPOLYSACCHARIDE (LPS) ANTIBODIES AND SUPPRESSION OF LPS-INDUCED TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-6 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) : 889 - 896

[3] BAUMGARTNER JD, 1985, LANCET, V2, P59

[4] ECHTENACHER B, 1990, J IMMUNOL, V145, P3762

[5] SEPTIC SHOCK - PATHOGENESIS [J]. LANCET, 1991, 338 (8769) : 732 - 736

[6] ENDOTOXIN ANTIBODY FOR SEPSIS IN INFANTS [J]. LANCET, 1992, 339 (8794) : 678 - 678

[7] OPAL SM, 1992, 32ND INT C ANT AG CH

[8] ROBERTS FJ, 1991, REV INFECT DIS, V13, P34

[9] SIEGEL JP, 1992, NEW ENGL J MED, V327, P890

[10] TONOLI M, 1992, 32ND INT C ANT AG CH

[1] BAUMGARTNER JD, 1987, REV INFECT DIS, V9, P194

[2] ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTI-LIPOPOLYSACCHARIDE (LPS) ANTIBODIES AND SUPPRESSION OF LPS-INDUCED TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-6 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) : 889 - 896

[3] BAUMGARTNER JD, 1985, LANCET, V2, P59

[4] ECHTENACHER B, 1990, J IMMUNOL, V145, P3762

[5] SEPTIC SHOCK - PATHOGENESIS [J]. LANCET, 1991, 338 (8769) : 732 - 736

[6] ENDOTOXIN ANTIBODY FOR SEPSIS IN INFANTS [J]. LANCET, 1992, 339 (8794) : 678 - 678

[7] OPAL SM, 1992, 32ND INT C ANT AG CH

[8] ROBERTS FJ, 1991, REV INFECT DIS, V13, P34

[9] SIEGEL JP, 1992, NEW ENGL J MED, V327, P890

[10] TONOLI M, 1992, 32ND INT C ANT AG CH